Vous êtes sur la page 1sur 7

Brand Name: Aspilet

Generic Name: Aspirin


Indication:
 Rheumatoid arthritis, osteoarthritis, or other polyarthritic or inflammatory
conditions
 Juvenile rheumatoid arthritis
 Mild pain or fever
 To prevent thrombosis
 To reduce of MI in patients with previous MI or unstable angina
 Kawasaki syndrome mucocutaneous lymph node syndrome
 Acute Rheumatic Fever
 To reduce the risk of recurrent transient ischemic attacks and stroke or death
in patients at risk
 Acute ischemic stroke
 Acute pericarditis after MI
Drug Classification: Antithrombotic, Anticoagulant, Fibrinolytic
Mechanism of Action: Produce analgesia by blocking pain impulses, probably by
inhibiting synthesis or prostaglandin in the CNS or of other substances that
sensitize pain receptors to mechanical or chemical stimulation. Relieve fever by central
action in the hypothalamic heat regulating center. Drug exerts its anti inflammatory
response as well. In low doses, aspirin also appears to impede clotting by blocking
prostaglandin synthesis, which prevents information of the platelet- aggregating
substance, thromboxane.
Dosage:
 Rheumatoid arthritis, osteoarthritis, or other polyarthritic or inflammatory
conditions: Adults: initially, 2.4 -3.6 g P.O. daily in divided doses.
Maintenance dosage is 3.2 to 6 g P.O daily in divided doses.
 Juvenile rheumatoid arthritis: Children: 60 – 110 mg/kg daily P.O divided
every 6 to 8 hours.
 Mild pain or fever: Adults and children older than age 11: 325 to 650 mg
P.O. or P.R. q 4 hours, p.r.n. Children ages 2 to 11: 10 to 15 mg/kg/dose P.O.
or P.R. q 4 Hours, up to 80 mg/kg daily.
 To prevent thrombosis: Adults: 1.3 g P.O daily in two to four divided doses.
 To reduce risk of MI in patients with previous MI or unstable angina:
Adults: 75-325 mg. P.O. daily

(Continuation Aspilet)
 Kawasaki syndrome (mucocutaneous lymph node syndrome): Adults: 80 to
180 mg/kg P.O. daily in four divided doses during febrile phase. When fever
subsides, decrease 10 mg/kg once daily and adjust according to salicylate
level.
 Acute Rheumatic Fever: Adults: 5 to 8 g P.O. daily Children: 100 mg/kg
daily P.O. for 4 to 6 weeks.
 To reduce the risk of recurrent transient ischemic attacks and stroke or death
in patients at risk: Adults: 50 to 325 mg P.O. daily.
 Acute ischemic stroke: Adults: 160 – 325 mg P.O daily started within 48
hours of stroke onset and continue for up to 2 -4 weeks.
 Acute pericarditis after MI: Adults: 160 to 325 mg P.O. daily. Higher doses
(650 mg P.O. q 4 to 6 hours) may be needed.
Special Precaution: 3rd trimester of pregnancy, lactation, and severe renal and hepatic
insufficiency. Children with viral illnesses.
Pregnancy Risk Category: C (D in third trimesters)
Adverse Reaction:
EENT: tinnitus, hearing loss
GI: nausea, GI distress, occult bleeding, dyspepsia, GI bleeding
Hematologic: leukopenia, thrombocytopenia, prolonged bleeding time
Hepatic: hepatitis
Skin: rash, bruising, urticaria
Other: angioedema, hypersensitivity reactions, Reye’s syndrome
Contraindications:
Contraindicated in patients hypersensitive to drug and in those with NSAID-
induce sensitivity reactions, G6PD deficiency, or bleeding disorders, such as
hemophilia, von Willebrand’s disease, or telangiectasia.
Form: Chewing gum: 227.5 g suppositories: 120 mg, 200mg, 300 mg, 600 mg
Tablets: 325 mg, 500 mg
Tablets (chewable): 81 mg
Tablets (controlled release): 80 mg
Tablets ( enteric-coated; 81 mg, 165 mg, 325 mg, 500 mg, 650 mg 975 mg
Tablets (timed-release): 650 mgs
(Continuation Aspilet)
Nursing Responsibility:
 Use cautiously in patients with GI lesions, impaired renal function,
hypoprothrombemia, vitamin K deficiency, thrombocytopenia, thrombotic
thrombocytopenic purpura, or severe hepatic impairment.
 Alert: because of epidemiologic link to Reye’s syndrome, the Centers for
Disease Control and Prevention recommended not giving salicylates to
children of teenagers with chickenpox or flu like illness.
 For inflammatory conditions, rheumatic fever, and thrombosis, aspirin is
administered on a schedule rather than p.r.n.
 Because enteric coated tablets are slowly absorbed, they aren’t suitable for
rapid relief of acute pain, fever, or inflammation. They cause less GI
bleeding and may be better suited for long – term therapy, such as treatment
of arthritis.
 For patient with swallowing difficulties crush non enteric – coated aspirin
and dissolve in soft food or liquid. Administer liquid immediately after
mixing because drug will break down rapidly.
 For patients who can’t tolerate oral drugs, ask prescriber about using aspirin
rectal suppositories. Watch for rectal mucosal irritation or bleeding.
 Febrile, dehydrated children can develop toxicity rapidly.
 Monitor elderly patients closely because they may be more susceptible to
aspirin’s toxic effects.
 Monitor salicylate levels. Therapeutic salicylate level in arthritis is 150 to
300 mcg ml. tinnitus may occur isn’t a reliable indicator of toxicity,
especially in very young patients and those older than age 60. with long-
term therapy, severe toxic effects may occur with levels of exceeding 400
mcg/ml
 During prolonged therapy, hematocrit ,hemoglobin, PT, INR, and renal
function should be assessed periodically
 Aspirin irreversibly inhibits platelet aggregation. It should be discontinued
5 to 7 days before elective surgery to allow time fro production and release
of new platelets.
 Monitor patient for hypersensitivity reactions such as anaphylaxis or
asthma.
 Alert: Don’t confuse aspirin with Ascendin or Afrin.